Free Preview
The FDA has cleared the single-source Nano.ARC machine, which will be used in tomosynthesis applications (checking for breast cancer). It’s a big step for the company which takes away some risk for investors. This is a major milestone for Nano-X, but much work remains as there are still manufacturing and distribution hurdles to be cleared. We’ll also be talking about Nike and its efforts to go direct-to-consumer which has shut out some major retailers.
